Core Insights - Bittensor is gaining attention due to its decentralized network designed for high-performance computing, particularly in machine learning and AI applications [1] - Despite a recent 4% decline in the last 24 hours, Bittensor has shown a remarkable 44% return over the past week, indicating strong performance [2] - Investor interest is driven by bullish expectations for ecosystem development, including new project announcements and a reduction in token emissions following a recent halving [5] Performance Metrics - Bittensor's recent performance includes a 4% decline in the last day but a 44% increase over the past week [2] - The network has approximately 100,000 on-chain accounts and over 2.5 million cumulative token transfers, showcasing solid underlying fundamentals [6] Future Outlook - The potential for increased interest in Bittensor's AI subnet infrastructure could lead to significant upside for the token, especially as geopolitical tensions ease [7] - There is a belief that the positive momentum for Bittensor will continue in the coming months [8]

“It’s exciting to work side by side with our ML researchers to solve drug discovery challenges that used to feel out of reach.” Simon Richards, Director of Computational Drug DesignOur Computational Drug Designers are at the heart of our transformative research, using our drug design engine to develop promising new medicines at a pace once thought impossible.We’re hiring Computational Drug Designers at all levels, see our latest roles here: https://t.co/Lh6gQfly7U ...

Core Insights - Workday, Inc. (WDAY) and International Business Machines Corporation (IBM) are key players in enterprise software and cloud solutions, with Workday focusing on cloud-based human capital management and financial management software, while IBM provides a broader range of cloud and data solutions for digital transformation [1][2] Workday Insights - Workday is expanding its offerings beyond core human capital management (HCM) into financial solutions, customizing for various industries, which has led to strong customer renewals and an expanding customer base [3] - The company is integrating advanced AI and machine learning capabilities into its products, focusing on improving decision-making and productivity through AI-powered features like Workday Illuminate [4] - Despite its growth, Workday derives 75% of its revenue from the U.S., which poses market risks due to economic downturns and competition, particularly from Oracle Corporation [5] IBM Insights - IBM is benefiting from strong demand for hybrid cloud and AI solutions, which are expected to drive growth in its Software and Consulting segments [6] - The acquisition of HashiCorp enhances IBM's capabilities in managing complex cloud environments, complementing its existing portfolio [8] - IBM faces competition from major players like Amazon AWS and Microsoft Azure, leading to pricing pressures and challenges in transitioning its business model to the cloud [9] Financial Performance - The Zacks Consensus Estimate for Workday's fiscal 2027 indicates sales growth of 11.6% and EPS growth of 14.2%, with flat EPS estimates over the past 60 days [10] - For IBM, the 2026 sales and EPS estimates suggest growth of 5.5% and 6.7%, respectively, with a slight upward trend in EPS estimates [12] - Over the past year, Workday's stock has declined by 46.9%, while IBM has lost 2.6%, indicating differing market performances [14] Valuation Comparison - From a valuation perspective, Workday appears more attractive with a price/sales ratio of 3.17 compared to IBM's 3.22 [14] - Both companies hold a Zacks Rank of 3 (Hold), but IBM shows better price performance and estimate revisions compared to Workday [15][16]

À 18 ans, Xiyao Li quitte la Chine pour la France sans parler un mot de français. Dix ans plus tard, diplômée de Polytechnique, elle utilise l'intelligence artificielle pour résoudre ce que la chimie traditionnelle met des décennies à accomplir : découvrir de nouveaux matériaux. Le problème : pour trouver un nouveau catalyseur ou un matériau, les chimistes testent des combinaisons une par une en laboratoire. Des années de travail pour explorer une infime fraction des possibilités. L'espace des molécules pos ...

Core Insights - Global Compliance Applications Corp. (GCAC) has entered into a definitive Engagement Agreement with Capital Trust Group Limited (CTG) to act as the Lead Blockchain Advisor and Compliance Auditor for CTG's "Project Accelerator," which aims to tokenize up to 100,000 SME and digital creator projects into institutional-grade Digital Bonds [1][4]. Group 1: Project Overview - CTG has committed a USD $3 billion contribution pool to subsidize issuance fees for qualifying projects, targeting a potential aggregate issuance volume of USD $1 trillion, focusing on the global creator economy with over 100 million active YouTube channels [2]. - The Project Accelerator will utilize GCAC's proprietary Efixii Ethereum Layer 2 infrastructure and machine learning solutions for technical and regulatory oversight [3]. Group 2: Revenue Potential - GCAC will charge a service fee of USD $400 for each project successfully onboarded into the Accelerator, with a maximum revenue potential of USD $40 million if all 100,000 projects are onboarded [3]. Group 3: Compliance and Verification - GCAC's compliance mandate includes performing exhaustive audits of project entities, personnel authentication, smart contract validation, and integrating blockchain-based mechanisms for bondholder engagement [5]. - The partnership positions GCAC as the compliance backbone for a significant digital bond issuance pipeline, enhancing access to global capital markets for SMEs and creators [4]. Group 4: Company Background - GCAC is recognized as a leader in designing blockchain and machine learning solutions for regulated industries, with its Efixii platform specializing in data integrity, compliance, and wallet technology [6]. - CTG has successfully issued over 600 Digital Bonds, bridging crypto-native assets and traditional capital markets [4].

AI isn't the future—it's now. Meet the Forbes 30 Under 30 revolutionaries harnessing machine learning to build robotic astronauts, cut off funding for terrorists, and turn anyone into a genius coder.This is the new class of innovators making history.See the full 2026 #ForbesUnder30 list: https://t.co/o5fMdPuFMs(Photography by Sebastian Nevols; Additional Photography by Guerin Blask) ...

Core Viewpoints - CoreWeave's business model relies on longer-dated "take-or-pay" contracts, providing visibility into future cash flows while incurring costs during hypergrowth, with stabilized margins in the mid-20s expected over the contract life [1][7] - The company has experienced a significant revenue increase from $200 million to $5 billion in a few years, with expectations to double again this year and in 2027, supported by a backlog of approximately $66 billion to $67 billion [2] Financing and Capital Expenditure - CoreWeave finances its rapid expansion through longer-dated "take-or-pay" contracts and asset-level delayed draw term loans (DDTLs), having financed about 90% of contract-level CapEx with DDTLs, with a total of $30 billion of CapEx tied to backlog [7][12] - The company anticipates substantial capital needs, with guidance including $30 billion of CapEx, primarily sourced from DDTLs, customer prepayments, and opportunistic top-level financings [12] Power Strategy and Infrastructure - CoreWeave prioritizes near-term, grid-connected power, with about 3.1 gigawatts of contracted power expected to be largely online by the end of 2027, and plans to scale self-build joint ventures to manage physical constraints [6][15] - The company emphasizes the importance of time to power and the source of power in site selection, typically contracting power 12 to 24 months before it comes online [13][14] Partnership and Product Expansion - CoreWeave is expanding its partnership with NVIDIA, targeting an additional 5 gigawatts of AI cloud capacity by 2030, and is focused on growing higher-margin add-on services beyond GPUs, which have reached a $100 million run rate [5][17] - The company is adapting to shifts in GPU technology and cooling methods, with a focus on liquid-cooled data centers and the adoption of newer GPU generations like Blackwell [18] Market Position and Execution - CoreWeave's approach to borrowing through DDTLs is based on specific contracted customer revenues, with a focus on contract quality and customer creditworthiness to drive lender confidence [8][10] - The company is focused on executing large compute builds while deploying newer technology, suggesting that the market may underestimate the sophistication required to deliver AI cloud at scale [19][20]

Core Viewpoint - Azitra, Inc. has received a notice of non-compliance from NYSE American regarding its stockholders' equity, which must meet specific requirements to maintain its listing status [1] Compliance Issues - Azitra is not in compliance with the NYSE American's continued listing standards under Section 1003(a)(iii), which requires stockholders' equity of $6 million or more due to reported losses [1] - Previously, on October 1, 2025, Azitra was notified of non-compliance with Section 1003(a)(ii), which requires a minimum stockholders' equity of $4 million if losses were reported in three of the last four fiscal years [1] - The company submitted a plan to regain compliance by April 1, 2027, which was accepted on December 16, 2025 [1] Timeline and Consequences - Azitra has until April 1, 2027, to regain compliance with the NYSE American's listing standards; failure to do so may result in delisting proceedings [1] - The company will remain listed during the compliance plan period and will undergo periodic reviews, including quarterly monitoring [1] Financial Health - The notice from the Exchange does not immediately affect the trading of Azitra's common stock or its business operations [1] - Azitra's audited financial statements for the year ended December 31, 2025, included a substantial doubt regarding the company's ability to continue as a going concern [1] Business Focus - Azitra is a clinical stage biopharmaceutical company focused on precision dermatology, with its lead program ATR-12 aimed at treating Netherton syndrome, a rare skin disease [1] - The company also has an advanced program ATR-04 for treating EGFR inhibitor-associated rash, which has received Fast Track designation from the FDA [1] - Azitra's proprietary platform includes a microbial library of approximately 1,500 bacterial strains, enhanced by AI and machine learning technology [1]

AI isn't the future—it's now. Meet the Forbes 30 Under 30 revolutionaries harnessing machine learning to build robotic astronauts, cut off funding for terrorists, and turn anyone into a genius coder.This is the new class of innovators making history.See the full 2026 #ForbesUnder30 list: https://t.co/o5fMdPuFMs(Photography by Sebastian Nevols; Additional Photography by Guerin Blask) ...

Fourth Quarter and Full Year 2025 Earnings Call March 12, 2026 Cautionary Statement Regarding Forward-looking Statements Pursuant to Safe Harbor Provisions of The Private Securities Litigation Reform Act of 1995 Cautionary Statement Regarding Forward-Looking Statements This presentation includes "forward-looking statements" as that term is defined under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning Kodak's plans, objectives, goals, strategies, ...